US Patent

US11083698 — Epinephrine compositions and containers

Method of Use · Assigned to Nevakar Inc · Expires 2039-03-21 · 13y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods for preparing and packaging epinephrine compositions with improved stability.

USPTO Abstract

The inventive subject matter provides ready-to-administer, preferably anti-oxidant free, epinephrine compositions with improved stability, and methods for preparing the same. Contemplated compositions can be packaged using blow-fill-seal technology or packaged into flexible IV bags and maintain degradation of the epinephrine at a level of less than 5 wt % when stored over at least one months at between 2-40° C.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-3567 — Epipen
U-3567 — Epipen
U-3567 — Epipen
U-3567 — Epipen
U-3567 — Epipen

Patent Metadata

Patent number
US11083698
Jurisdiction
US
Classification
Method of Use
Expires
2039-03-21
Drug substance claim
No
Drug product claim
No
Assignee
Nevakar Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.